Cargando…

Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a severe disease characterized by the loss and obstructive remodeling of the pulmonary arterial wall, causing a rise in pulmonary arterial pressure and pulmonary vascular resistance, which is responsible for right heart failure, functional decline, and death....

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Gloria, José L., Osorio-Alonso, Horacio, Arellano-Buendía, Abraham S., Carbó, Roxana, Hernández-Díazcouder, Adrián, Guzmán-Martín, Carlos A., Rubio-Gayosso, Ivan, Sánchez-Muñoz, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402298/
https://www.ncbi.nlm.nih.gov/pubmed/32650586
http://dx.doi.org/10.3390/ijms21144827
_version_ 1783566727991263232
author Sánchez-Gloria, José L.
Osorio-Alonso, Horacio
Arellano-Buendía, Abraham S.
Carbó, Roxana
Hernández-Díazcouder, Adrián
Guzmán-Martín, Carlos A.
Rubio-Gayosso, Ivan
Sánchez-Muñoz, Fausto
author_facet Sánchez-Gloria, José L.
Osorio-Alonso, Horacio
Arellano-Buendía, Abraham S.
Carbó, Roxana
Hernández-Díazcouder, Adrián
Guzmán-Martín, Carlos A.
Rubio-Gayosso, Ivan
Sánchez-Muñoz, Fausto
author_sort Sánchez-Gloria, José L.
collection PubMed
description Pulmonary arterial hypertension (PAH) is a severe disease characterized by the loss and obstructive remodeling of the pulmonary arterial wall, causing a rise in pulmonary arterial pressure and pulmonary vascular resistance, which is responsible for right heart failure, functional decline, and death. Although many drugs are available for the treatment of this condition, it continues to be life-threatening, and its long-term treatment is expensive. On the other hand, many natural compounds present in food have beneficial effects on several cardiovascular conditions. Several studies have explored many of the potential beneficial effects of natural plant products on PAH. However, the mechanisms by which natural products, such as nutraceuticals, exert protective and therapeutic effects on PAH are not fully understood. In this review, we analyze the current knowledge on nutraceuticals and their potential use in the protection and treatment of PAH, as well as whether nutraceuticals could enhance the effects of drugs used in PAH through similar mechanisms.
format Online
Article
Text
id pubmed-7402298
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74022982020-08-07 Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension Sánchez-Gloria, José L. Osorio-Alonso, Horacio Arellano-Buendía, Abraham S. Carbó, Roxana Hernández-Díazcouder, Adrián Guzmán-Martín, Carlos A. Rubio-Gayosso, Ivan Sánchez-Muñoz, Fausto Int J Mol Sci Review Pulmonary arterial hypertension (PAH) is a severe disease characterized by the loss and obstructive remodeling of the pulmonary arterial wall, causing a rise in pulmonary arterial pressure and pulmonary vascular resistance, which is responsible for right heart failure, functional decline, and death. Although many drugs are available for the treatment of this condition, it continues to be life-threatening, and its long-term treatment is expensive. On the other hand, many natural compounds present in food have beneficial effects on several cardiovascular conditions. Several studies have explored many of the potential beneficial effects of natural plant products on PAH. However, the mechanisms by which natural products, such as nutraceuticals, exert protective and therapeutic effects on PAH are not fully understood. In this review, we analyze the current knowledge on nutraceuticals and their potential use in the protection and treatment of PAH, as well as whether nutraceuticals could enhance the effects of drugs used in PAH through similar mechanisms. MDPI 2020-07-08 /pmc/articles/PMC7402298/ /pubmed/32650586 http://dx.doi.org/10.3390/ijms21144827 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sánchez-Gloria, José L.
Osorio-Alonso, Horacio
Arellano-Buendía, Abraham S.
Carbó, Roxana
Hernández-Díazcouder, Adrián
Guzmán-Martín, Carlos A.
Rubio-Gayosso, Ivan
Sánchez-Muñoz, Fausto
Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension
title Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension
title_full Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension
title_fullStr Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension
title_full_unstemmed Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension
title_short Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension
title_sort nutraceuticals in the treatment of pulmonary arterial hypertension
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402298/
https://www.ncbi.nlm.nih.gov/pubmed/32650586
http://dx.doi.org/10.3390/ijms21144827
work_keys_str_mv AT sanchezgloriajosel nutraceuticalsinthetreatmentofpulmonaryarterialhypertension
AT osorioalonsohoracio nutraceuticalsinthetreatmentofpulmonaryarterialhypertension
AT arellanobuendiaabrahams nutraceuticalsinthetreatmentofpulmonaryarterialhypertension
AT carboroxana nutraceuticalsinthetreatmentofpulmonaryarterialhypertension
AT hernandezdiazcouderadrian nutraceuticalsinthetreatmentofpulmonaryarterialhypertension
AT guzmanmartincarlosa nutraceuticalsinthetreatmentofpulmonaryarterialhypertension
AT rubiogayossoivan nutraceuticalsinthetreatmentofpulmonaryarterialhypertension
AT sanchezmunozfausto nutraceuticalsinthetreatmentofpulmonaryarterialhypertension